Clinical Trial Detail

NCT ID NCT01937715
Title A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Pfizer
Indications

colorectal cancer

Therapies

Bevacizumab

Gedatolisib

Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult

Additional content available in CKB BOOST